XGES holdings
As of , XGES (MSCI Genomic Healthcare Innov UCITS ETF, ISIN IE000KD0BZ68) has 100 holdings on our record. The fund reports 104 positions in all. Weights are shares of the whole fund.
- Holdings
- 100
- 104 reported in all
- Ten largest
- 46.7%
- of the whole fund
- Effective number of holdings
- 32
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 6.0%
- Moderna
Where it invests
Every line of each split, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By country
Added up from the fund’s published holdings, as of 15/11/2026.
- United States67.4%
- Switzerland12.6%
- China8.5%
- Netherlands5.6%
- United Kingdom4.5%
- Spain0.4%
- Sweden0.3%
- Australia0.2%
- Japan0.2%
- Italy0.1%
- South Korea0.1%
- Not classified0.1%
By type of asset
Added up from the fund’s published holdings, as of 15/11/2026.
- Equity99.9%
- Cash and money market0.1%
More ways to cut the portfolio
The fund's portfolio is also split by currency.
Create a free account to see the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
More:XGES: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published on 15/11/2026 and change as the fund trades. This is information, not advice.